Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Patients received pre-prepared investigational product from Eli Lilly
W.le RouxC
[VERIFY: confirm typical timeline observations with clinical team] SS-31 has been studied in multiple clinical trials, including the Phase 3 TAZPOWER trial and earlier Phase 2 studies in heart failure, with a consistent safety profile
Does not affect blood glucose or insulin levels, avoiding the potential metabolic risks associated with hGH therapy
US$ 25.03
US$ 29.90
US$ 29.69
US$ 20.55
US$ 22.43
US$ 23.11
US$ 21.74
US$ 22.45
US$ 23.27
,aspect=ignore)
US$ 22.38
US$ 28.36
US$ 20.76
